Grifols Current Ratio 2012-2018 | GRFS

Current and historical current ratio for Grifols (GRFS) from 2012 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Grifols current ratio for the three months ending September 30, 2018 was 0.00.
Grifols Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $3.52B $1.26B 2.78
2018-06-30 $3.52B $1.21B 2.90
2017-06-30 $3.14B $0.99B 3.17
2017-03-31 $3.15B $1.01B 3.13
2016-12-31 $3.46B $1.19B 2.91
2016-09-30 $3.30B $1.03B 3.19
2016-06-30 $3.30B $1.10B 3.00
2016-03-31 $3.26B $0.99B 3.31
2015-12-31 $3.43B $1.17B 2.93
2015-09-30 $3.16B $1.09B 2.91
2015-06-30 $3.04B $1.11B 2.74
2015-03-31 $3.19B $1.13B 2.82
2014-12-31 $3.87B $1.44B 2.70
2014-09-30 $3.59B $1.31B 2.75
2014-06-30 $3.31B $1.09B 3.03
2014-03-31 $3.31B $1.02B 3.25
2013-12-31 $2.84B $0.95B 2.99
2013-09-30 $2.63B $0.87B 3.02
2013-06-30 $2.66B $0.97B 2.75
2013-03-31 $2.56B $0.81B 3.17
2012-12-31 $2.49B $0.76B 3.26
2012-09-30 $2.40B $0.80B 3.00
2012-06-30 $2.44B $0.87B 2.80
2012-03-31 $2.32B $0.87B 2.68
2011-12-31 $2.69B $0.90B 2.99
2011-09-30 $2.38B $0.79B 3.02
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.851B $4.878B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $51.794B 11.05
Zoetis (ZTS) United States $43.144B 29.54
Tilray (TLRY) United States $8.764B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $8.468B 12.15
Neurocrine Biosciences (NBIX) United States $7.777B 1715.20
Ionis Pharmaceuticals (IONS) United States $7.422B 0.00
Nektar Therapeutics (NKTR) United States $6.306B 9.04
Catalent (CTLT) United States $5.273B 22.12
Sage Therapeutics (SAGE) United States $5.056B 0.00
Impax Laboratories (AMRX) United States $4.974B 26.44
United Therapeutics (UTHR) United States $4.785B 7.83
Loxo Oncology (LOXO) United States $4.206B 0.00
TESARO (TSRO) United States $4.087B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.489B 12.92
FibroGen (FGEN) United States $3.379B 0.00
USANA Health Sciences (USNA) United States $2.908B 24.75
Endo (ENDP) Ireland $2.515B 3.85
Xencor (XNCR) United States $2.110B 0.00
Heron Therapeutics (HRTX) United States $2.102B 0.00
Corcept Therapeutics (CORT) United States $1.983B 29.10
Endocyte (ECYT) United States $1.957B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.932B 261.11
Ironwood Pharmaceuticals (IRWD) United States $1.873B 0.00
Aerie Pharmaceuticals (AERI) United States $1.842B 0.00
Zogenix (ZGNX) United States $1.832B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.765B 0.00
PTC Therapeutics (PTCT) United States $1.749B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.538B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.438B 20.23
Esperion Therapeutics (ESPR) United States $1.418B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.368B 0.00
Tricida (TCDA) United States $1.361B 0.00
Portola Pharmaceuticals (PTLA) United States $1.295B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.199B 0.00
TherapeuticsMD (TXMD) United States $1.006B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.976B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.814B 0.00
ImmunoGen (IMGN) United States $0.805B 0.00
Radius Health (RDUS) United States $0.743B 0.00
Karyopharm Therapeutics (KPTI) United States $0.625B 0.00
Collegium Pharmaceutical (COLL) United States $0.618B 0.00
Forty Seven (FTSV) United States $0.582B 0.00
Flexion Therapeutics (FLXN) United States $0.544B 0.00
Akebia Therapeutics (AKBA) United States $0.522B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.517B 0.00
ChemoCentryx (CCXI) United States $0.510B 40.40
Siga Technologies (SIGA) United States $0.489B 0.00
Dermira (DERM) United States $0.462B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.460B 0.00
GlycoMimetics (GLYC) United States $0.458B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.445B 26.23
Dova Pharmaceuticals (DOVA) United States $0.436B 0.00
Tyme Technologies (TYME) United States $0.425B 0.00
Xeris Pharmaceuticals (XERS) United States $0.421B 0.00
Translate Bio (TBIO) United States $0.409B 0.00
Odonate Therapeutics (ODT) United States $0.409B 0.00
KalVista Pharmaceuticals (KALV) United States $0.398B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.395B 0.00
ArQule (ARQL) United States $0.377B 0.00
CASI Pharmaceuticals (CASI) United States $0.370B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.367B 0.00
Majesco Entertainment (PTE) United States $0.358B 0.00
Aclaris Therapeutics (ACRS) United States $0.336B 0.00
Tapimmune (MRKR) United States $0.328B 0.00
OptiNose (OPTN) United States $0.321B 0.00
Minerva Neurosciences (NERV) United States $0.309B 0.00
Aratana Therapeutics (PETX) United States $0.307B 0.00
Concert Pharmaceuticals (CNCE) United States $0.306B 0.00
Depomed (ASRT) United States $0.270B 10.05
Mast Therapeutics (SVRA) United States $0.267B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.257B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.255B 0.00
IMV INC (IMV) Canada $0.250B 0.00
Aldeyra Therapeutics (ALDX) United States $0.249B 0.00
Ocular Therapeutix (OCUL) United States $0.240B 0.00
Affimed (AFMD) Germany $0.227B 0.00
Aquestive Therapeutics (AQST) United States $0.214B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Lannett Co Inc (LCI) United States $0.207B 1.79
Foamix Pharmaceuticals (FOMX) Israel $0.207B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.207B 0.00
Zafgen (ZFGN) United States $0.195B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.195B 0.00
TAIWAN LIPOSOME (TLC) Taiwan $0.194B 0.00
Opexa Therapeutics (ACER) United States $0.193B 0.00
Calithera Biosciences (CALA) United States $0.185B 0.00
MEI Pharma (MEIP) United States $0.175B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.170B 0.00
Recro Pharma (REPH) United States $0.168B 0.00
ContraFect (CFRX) United States $0.160B 0.00
Neon Therapeutics (NTGN) United States $0.159B 0.00
Molecular Templates (MTEM) United States $0.156B 0.00
Ardelyx (ARDX) United States $0.151B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.151B 0.00
Redhill Biopharma (RDHL) Israel $0.149B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.144B 0.00
ElectroCore (ECOR) United States $0.140B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.139B 0.00
MediWound (MDWD) Israel $0.138B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.126B 0.00
Cardiome Pharma (CORV) Canada $0.126B 0.00
DURECT (DRRX) United States $0.121B 0.00
Jounce Therapeutics (JNCE) United States $0.121B 0.00
Adherex Technologies (FENC) United States $0.119B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Rafael Holdings (RFL) United States $0.113B 0.00
ProNAi Therapeutics (SRRA) Canada $0.108B 0.00
Iterum Therapeutics (ITRM) Ireland $0.103B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.094B 0.00
Immune Design (IMDZ) United States $0.093B 0.00
CTI BioPharma (CTIC) United States $0.087B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.086B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.086B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.084B 0.00
Achaogen (AKAO) United States $0.080B 0.00
Melinta Therapeutics (MLNT) United States $0.078B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.078B 0.00
Natural Alternatives (NAII) United States $0.078B 7.68
Otonomy (OTIC) United States $0.077B 0.00
KemPharm (KMPH) United States $0.074B 0.00
Infinity Pharmaceuticals (INFI) United States $0.072B 0.00
BioLineRx (BLRX) Israel $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.068B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.061B 37.86
Neos Therapeutics (NEOS) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.058B 0.00
Avenue Therapeutics (ATXI) United States $0.056B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.051B 0.00
Genocea Biosciences (GNCA) United States $0.050B 0.00
Mannatechorporated (MTEX) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.048B 0.00
Novan (NOVN) United States $0.039B 0.00
Capnia (SLNO) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.036B 4.08
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Trillium Therapeutics (TRIL) Canada $0.032B 0.00
Heat Biologics (HTBX) United States $0.031B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.030B 0.00
Lipocine (LPCN) United States $0.029B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
IsoRay (ISR) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.026B 0.00
Can-Fite Biopharma (CANF) Israel $0.026B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
NanoViricides (NNVC) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
HANCOCK JAFFE (HJLI) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.021B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Aviragen Therapeutics (VXRT) United States $0.019B 0.00
Onconova Therapeutics (ONTX) United States $0.019B 0.00
Pain Therapeutics (PTIE) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.018B 6.35
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Citius Pharmaceuticals (CTXR) United States $0.017B 0.00
ESSA Pharma (EPIX) Canada $0.016B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Shineco (TYHT) China $0.014B 1.49
DelMar Pharmaceuticals (DMPI) Canada $0.011B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Aradigm (ARDM) United States $0.010B 0.00
Skyline Medical (AIPT) United States $0.009B 0.00
Apricus Biosciences (APRI) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Midatech Pharma (MTP) United Kingdom $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.003B 0.00
Intellipharmaceutics (IPCI) Canada $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
AGEX THERAPEUTC (AGE) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00